Life sciences news
-
Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia
Tuesday November 15th 2022
Read more
-
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
Friday November 4th 2022
Read more
-
Indigo Diabetes incorporates fully owned subsidiary in the US and appoints Peter J. Devlin as President, Indigo Medical US Inc.
Thursday October 27th 2022
Read more
-
ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers
Monday September 12th 2022
Read more
-
BioLizard is now an Official Illumina Connected Analytics Implementation Partner
Monday September 5th 2022
Read more
-
NEXTSTELLIS® oral contraceptive now available in Australia
Tuesday July 26th 2022
Read more
-
ImmuneWatch signs licence agreement with UAntwerp and UZA and officially becomes a university spin-off company
Friday June 24th 2022
Read more
-
Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software
Tuesday May 31st 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Precirix strengthens patent portfolio of its precision radiopharmaceuticals platform
Tuesday May 31st 2022
Read more
-
Belgian biotech in European Top-3 despite turbulent times
Wednesday May 18th 2022
Read more
-
flanders.bio appoints CEO and COO in newly created role
Wednesday May 18th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
